Jeremy Steven Davis - 20 Apr 2022 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role
SVP Chief Commercial Officer
Signature
/s/ Jeremy Davis by Nicholas Khadder, Attorney-in-Fact
Issuer symbol
LAB
Transactions as of
20 Apr 2022
Net transactions value
$0
Form type
4
Filing time
21 Apr 2022, 18:21:02 UTC
Previous filing
06 Apr 2022
Next filing
20 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LAB Restricted Stock Units Award $0 +250,000 $0.000000 250,000 20 Apr 2022 Common Stock 250,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.
F2 Restricted Stock Units vest as to 1/4th of the underlying shares on May 20, 2023, and as to an additional 1/16th of the total number of shares each quarter thereafter.